First Tracks Biotherapeutics, Inc. (TRAX) Reports Q2 Loss of $0.95

Go back to First Tracks Biotherapeutics, Inc. (TRAX) Reports Q2 Loss of $0.95
(NASDAQ: TRAX) Delayed: 44.03 -2.1 (4.55%)
Previous Close $46.13    52 Week High
Open $46.15    52 Week Low
Day High $46.79    P/E N/A 
Day Low $43.00    EPS
Volume 715,085